An evaluation of mycophage therapy, chemotherapy and vaccination for control of Mycobacterium avium subsp. paratuberculosis infection

Veterinary Microbiology

Volumn 104, Issue 3-4, 2004, Pages 143-155

  Emery, David L ^a   Whittington, Richard J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chemotherapy; Control; Mycobacterium paratuberculosis; Mycophages; Vaccines

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; BCG VACCINE; GUDAIR; NEO PARASEC; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CORRELATION ANALYSIS; DRUG EFFICACY; INCIDENCE; INFECTION CONTROL; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; NEMATODE; NONHUMAN; PARATUBERCULOSIS; REVIEW; TREATMENT PLANNING; VACCINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL VACCINES; MYCOBACTERIOPHAGES; MYCOBACTERIUM PARATUBERCULOSIS; PARATUBERCULOSIS; SHEEP; SHEEP DISEASES; VACCINATION;

MYCOBACTERIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; OVIS; OVIS ARIES;

EID: 9644274130     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2004.08.014     Document Type: Review

References (101)

1. J. Alisky, K. Iczkowski, A. Rapaport, and N. Troitsky Bacteriophages show promise as antimicrobial agents J. Infect. 36 1997 5 15
2. Anon accessed 07-05-2004. Phage Therapy. In Phage Biotech Ltd. (www.phage-biotech.com/links.html), 6 pp.
3. G. Argent Efficiency of vaccination and other control measures estimated by fecal shedding in a regional control program 3rd International Colloquium on Paratuberculosis 1991 495 498
4. C. Barrios, C. Brandt, M. Berney, P.H. Lambert, and C.A. Siegrist Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant affects Eur. J. Immunol. 26 1996 2666 2670
5. P.A. Barrow, and J.S. Soothill Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential Trends Microbiol. 5 1997 268 271
6. A. Belloli, S. Carli, D. Pravettoni, D. Proverbio, M. Giangaspero, S. Lauzi, and L. Bonizzi Case-study-attempted treatment of a cow with Mycobacterium paratuberculosis enterocolitis Bovine Practioner 35 2001 56 60
7. P. Bisen, S.K. Garg, R.P. Tiwari, P.R. Tagore, R. Chandra, R. Karnik, N. Thaker, N. Desai, P.K. Ghosh, M. Fraziano, and V. Colizzi Analysis of the shotgun expression library of the Mycobacterium tuberculosis genome for immunodominant polypeptides: potential use in serodiagnosis Clin. Diag. Lab. Immunol. 10 2003 1051 1058
8. T.J. Borody, S. Leis, E.F. Warren, and R. Surace Treatment of severe Crohn's disease using antimycobacterial triple therapy-approaching a cure? Dig. Liver Dis. 34 2002 29 38
9. B.U. Bowman, and T.M. Daniel Further evidence against the concept of decreased phage neutralising ability of serum from patients with sarciodosis Am. Rev. Resp. Dis. 104 1971 908 914
10. L. Brandt, J.F. Cunha, A.W. Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Anderson Failure of Mycobacterium bovis BCG vaccine: some species of environmental bacteria block multiplication of BCG and induction of protective immunity in tuberculosis Inf. Immunol. 70 2002 672 678
11. P. Bretscher, D. Hamilton, and O. Ogunremi What information is needed to design effective vaccination against intracellular pathogens causing chronic disease? Exp. Rev. Vaccines 1 2002 179 192
12. P. Bretscher, G. Wei, J.N. Menon, and H. Bielefeldt-Ohmann Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major Science 257 1992 539 542
13. J. Brotherston, N.J.L. Gilmour, and J.Mc A. Samuel Quantitative studies on Mycobacterium johnei in sheep II. Protection afforded by dead vaccines J. Comp. Path. 71 1961 300 311
14. L. Broxmeyer, D. Sosnowska, E. Miltner, O. Chacon, D. Wagner, J. McGarvey, R.G. Barletta, and L.E. Bermudez Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens J. Inf. Dis. 186 2002 1155 1160
15. G. Brumbaugh, J.F. Edwards, A.J. Roussel, and T.D. Thomson Effect of monensin sodium on histological lesions of naturally occuring bovine paratuberculosis J. Comp. Path. 123 2000 22 28
16. B. Buddle, G.W. de Lisle, A. Pfeffer, and F.E. Aldwell Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG Vaccine 13 1995 1123 1130
17. M. Buraczewska, W. Manowska, and H. Rdultowska Induction of phages from lysogenic Mycobacteria by means of ultra-violet irradiation Am. Rev. Resp. Dis. 104 1971 760 772
18. R. Bush, J.-A. Torribo, and P. Windsor Mortality due to OJD preliminary results of a 12 months study Australian Sheep Veterinary Society Cairns, Australia 2003 96 101
19. R. Carlton Phage therapy: past history and future prospects Arch. Immunol. Ther. Exp. 47 1999 267 274
20. J.C. Cater, and W.B. Redmond Isolation and studies on bacteriophage lytic for mycobacteria Bact. Proc. 83 1960 242 248
21. J.C. Cater, and W.B. Redmond Mycobacterial phages isolated from stool specimens of patients with pulmonary disease Am. J. Resp. Dis. 87 1963 726 733
22. P. Chaitaweesub, K.A. Abbott, R.W. Whittington, and D.J. Marshall Shedding of organisms and sub-clinical effects on production in pre-clinical Merino sheep infected with ovine paratuberculosis Proceedings of the Sixth International Colloquium on Paratuberculosis Madison, USA 1999 126 131
23. H. Collins, and S.H.E. Kaufmann Prospects for better tuberculosis vaccines Lancet Infect. Dis. 1 2001 21 28
24. M.J. Corbel, and J.A. Morris Investigation of the effect of brucella-phage on the course of experimental infection with Brucella abortus Br. Vet. J. 136 1980 278 289
25. J.M. Corpa, V. Perez, and J.F. Garcia Marin Differences in the immune responses in lambs and kids vaccinated against paratuberculosis, according to the age of vaccination Vet. Microbiol. 77 2000 475 485
26. M.P. Cranwell Control of Johne's disease in a flock of sheep by vaccination Vet. Rec. 133 1993 219 220
27. R. Crowther, K. Polydorou, S. Nitti, and A. Phyrilla Johne's disease in Cyprus Vet. Rec. 77 1976 463 465
28. T. Doyle Vaccination against Johne's disease Vet. Rec. 76 1964 73 76
29. D.L. Emery, S.J. McClure, R.J. Davey, and T. Bendixsen Induction of protective immunity to Trichstrongylus colubrifromis in neonatal Merino lambs Int. J. Parasitol. 29 1999 1037 1046
30. H.W. Engel Mycobacteriophages and phage typing Ann. Microbiol. 129 1978 75 90
31. J. Eppleston, P. Windsor, R. Whittington, A. Britton, and S. Jones Australian trial to evaluate the efficacy of Gudair™ OJD vaccine Aust. Sheep Vet. Soc. 12 2002 22 27
32. J.E. Flaherty, B.K. Harbaugh, J.B. Jones, G.C. Somodi, and L.E. Jackson H-mutant bacteriophages as a potential biocontrol of bacterial blight of geraniums Hortscience 36 2001 98 100
33. E.M. Foley-Thomas, D.L. Whipple, L.E. Bermudez, and R.G. Barletta Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis Microbiology 141 1995 1173 1181
34. V. Fridriksdottir, S. Hjartardottir, S. Poulsen, S. Sigurdarson, and E. Gunnarsson Paratuberculosis in sheep in Iceland-is eradiction by vaccination possible? 7th International Colloquium on Paratuberculosis Bilbao, Spain 2002 517
35. S. Froman, D.W. Will, and E. Bogen Bacteriophages active against virulent Mycobacterium tuberculosis; isolation and activity Am. J. Pub. Health 44 1954 1326 1332
36. Garcia Pariente, C., Gonzalez, J., Ferreras, M.C., Feurtes, M., Benavides, J., Reyes, L.E., Moreon, O., Garcia Marin, J.F., Perez, V., 2002. Paratuberculosis vaccination of adult animals in flocks of dairy sheep. In: 7th International Colloquium on Paratuberculosis, Bilbao, Spain, pp. 507-510.
37. N. Gilmour, W.A. Halhead, and J.G. Brotherston Studies on immunity to Mycobacterium johnei in sheep J. Comp. Path. 75 1965 165 173
38. J.M. Grange Host-phage relationships in the genus Mycobacterium and their clinical significance Tuberculosis 59 1978 203 225
39. J. Gwozdz, K.G. Thompson, B.W. Manktelow, A. Murray, and D.M. West Vaccination against paratuberculosis of lambs already infected experimentally with Mycobacterium avium subspecies paratuberculosis Aust. Vet. J. 78 2000 560 566
40. A. Hailu, J. Menon, and N. Berhe Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people; implications for the mechanism underlying drug cure J. Inf. Dis. 184 2001 112 115
41. P. Hauduroy, and W. Rosset Essai de traitement de la tuberculose experimentale du cobaye avec un bacteriophage specifique Comp. Rend. Seances Soc. Biol. Filiales 154 1960 265 270
42. P. Hauduroy, and W. Rosset Tentative de traitment des hamsters inocules avec le BCG par un bacteriophage Ann. Past. Inst. 104 1963 419 425
43. J. Hermon-Taylor, and T. Bull Crohn's disease caused by Mycobacterium avium subspecies paratuberculosis: a public health tragedy whose resolution is long overdue J. Med. Microbiol. 51 2002 3 6
44. P. Holt Primary allergic sensitization to environmental antigens: perinatal T cell priming as a determinant of responder phenotype in adulthood J. Exp. Med. 183 1996 1297 1301
45. R. Hsia, H. Ohayon, P. Guonon, A. Dautry-Varsat, and P.M. Bavoil Phage infection of the obligate intracellular bacterium Chlamydia psittaci strain guinea pig inclusion conjunctivitis Microbe. Inf. 2 2000 761 772
46. K. Hulten, A. Almashrawi, F.A.K. El-Zaatari, and D.Y. Graham Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria (Review) Dig. Dis. Sci. 45 2000 445 456
47. R. Juste, J.F. Garcia-Marin, B. Peris, C. Saez de Ocariz, and J.J. Badiola Experimental infection of vaccinated and non-vaccinated lambs with Mycobacterium paratuberculosis J. Comp. Path. 110 1994 185 194
48. C. Kalis, M.T. Collins, J.W. Hesselink, and H.W. Barkema Rapid eradication of paratuberculosis 7th International Colloquium on Paratuberculosis Bilbao, Spain 2002 413 416
49. C.H. Kalis, J.W. Hesselink, H.W. Barkema, and M.T. Collins Use of long-term vaccination with a killed vaccine to prevent fecal shedding of Mycobacterium avium subsp. paratuberculosis in dairy herds Am. J. Vet. Res. 62 2001 270 274
50. B. Kormendy The effect of vaccination on the prevalence of paratuberculosis in large dairy herds Vet. Microbiol. 41 1994 117 125
51. Kutter, E. 1997. Phage therapy: bacteriophages as antibiotics. t4phage@evergreen.edu, pp. 22.
52. A. Larsen, A.I. Moyle, and E.M. Himes Experimental vaccination of cattle against paratuberculosis (Johne's disease) with killed bacterial vaccines: a controlled field study Am. J. Vet. Res. 39 1978 65 69
53. B. Leverentz, W.S. Conway, Z. Alavidze, W.J. Janisiewicz, Y. Fuchs, M.J. Camp, E. Chighladze, and A. Sulakvelidze Examination of bacteriophage as a biocontrol method for salmonella on fresh-cut fruit; a model study J. Fruit Protect. 64 2001 1116 1121
54. B. Levin, and J. Bull Phage therapy revisited; the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics Am. Nat. 147 1996 881 898
55. M.J. Loessner, and M. Busse Bacteriophage typing of Listeria species Appl. Env. Microbiol. 56 1990 1912 1918
56. E. Mankiewcz, and J. Beland The role of mycobacteriophages and of cortisone in experimental tuberculosis and sarcoidosis Am. Rev. Resp. Dis. 89 1964 707 714
57. D. McMurray Recent progress in the development and testing of vaccines against human tuberculosis Int. J. Parasitol. 33 2003 547 554
58. C.R. Merril, B. Biswas, R. Carlton, N.C. Jensen, G.J. Creed, S. Zullo, and S. Adhya Long-circulating bacteriophage as antibacterial agents Proc. Natl. Acad. Sci. U.S.A. 8 1996 3188 3192
59. K. Parent, and I.D. Wilson Mycobacteriophages in Crohn's disease Gut 12 1971 1019 1022
60. M. Paustian, A. Amonsin, V. Kapur, and J.P. Bannantine Characterization of novel coding sequences specific to Mycobacterium avium subsp. paratuberculosis; implication for diagnosis of Johne's disease J. Clin. Micro. 42 2004 2657 2681
61. R.J.H. Payne, and V. Jansen Understanding bacteriophage therapy as a density-dependent kinetic process J. Theoret. Biol. 208 2001 37 48
62. M.L. Pedulla, M.E. Ford, J.M. Houtz, T. Karthikeyan, C. Wadswoth, J.A. Lewis, D. Jacobs-Sera, J. Falbo, J. Gross, N.R. Pannunzio, W. Brucker, V. Kumar, J. Kandasamy, L. Keenan, S. Bardarov, J. Kriakov, J.G. Lawrence, W.R. Jacobs Jr., R.W. Hendrix, and G.F. Hatfull Origins of highly mosaic mycobacteriophage genomes Cell 113 2003 141
63. J. Piguet Presence de deux varietes distinctes dans une souche de mycobacteriophage Ann. Inst. Pasteur 98 1960 147 151
64. L. Reddacliff, and R.W. Whittington Experimental infection of weaner sheep with S strain Mycobacterium avium subsp. paratuberculosis Vet. Microbiol. 96 2003 247 258
65. R.L. Russell, G.J. Jann, and S. Froman Lysogeny in the mycobacteria. 1. Establishment of lysogeny Am. Rev. Resp. Dis. 82 1960 384 393
66. I. Sakaguchi, K. Shinshima, K. Kawaratani, and O. Sugai Control of microbiofouling using bacteriophage. 2. Detection of phages and fundamental study of their lytic effect on fouling bacteria Denryoku Chuo Kenkyusho Hokoku 5 1989 1 32
67. B. Seaworth Multi-drug resistant tuberculosis Inf. Dis. Clin. North Am. 16 2002 73 76
68. E.S.G. Sergeant Cost-effectiveness of vaccination against ovine Johne's disease in infected flocks Australia Sheep Veterinary Society Proceedings Cairns, Australia 2003 123 127
69. I. Shafran, L. Kugler, F.A. El-Zaatari, S.A. Naser, and J. Sandoval Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease Dig. Liver Dis. 34 2002 22 28
70. I. Shafran, L. Kugler, F.A.K. El-Zaatari, S.A. Naser, and J. Sandoval Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease Dig. Liver Dis. 34 2002 22 28
71. D.R. Shaw, A.T. Maurelli, J.D. Goguen, S.C. Straley, and R. Curtiss III Use of UV-irradiated bacteriophage T6 to kill extracellular bacteria in tissue culture infectivitiy assays J. Immunol. Method 56 1983 75 83
72. S. Shin, H.S. Yoo, S.P. McDonough, and Y.F. Chang Comparative antibody response of five recombinant antigens related to bacterial shedding levels and development of serological diagnosis based on 35 kDa antigen for Mycobacterium avium subsp. paratuberculosis J. Vet. Sci. 5 2004 111 117
73. B. Sigurdsson A killed vaccine against paratuberculosis (Johne's disease) in sheep Am. J. Vet. Res. 21 1964 54 67
74. M.A. Skinner, B.M. Buddle, D.N. Wedlock, D. Keen, G.W. de Lisle, R.E. Tascon, J.C. Ferraz, D.B. Lowrie, P.J. Cockle, H.M. Vordermeier, and R.G. Hewinson A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Inf. Immunol. 71 2003 4901 4907
75. R. Slocombe Combined streptomycin-isoniazid-rifampin therapy in the treatment of Johne's disease in a goat Can. Vet. J. 23 1982 160 163
76. S. Slopek, I. Durlakowa, B. Weber-Dabrowska, A. Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results Arch. Immunol. Ther. Exp. 31 1983 267 291
77. S. Slopek, B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz-Krukowska Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986 Arch. Immunol. Ther. Exp. 35 1987 569 583
78. R. Stone Bacteriophage therapy. Food and agriculture: testing grounds for phage therapy Science 298 2002 730
79. P. Stuart Vaccination against Johne's disease in cattle exposed to experimental infection Br. Vet. J. 121 1965 289 317
80. L. Sula, L. Sulova, and M. Stolcpartova Therapy of experimental tuberculosis in guinea pigs with mycobacterila phages DS-6A, GR-21T My-327 Czech. Med. 4 1981 209 214
81. A. Sulakvelidze, Z. Alavidze, and J.G. Morris Jr. Bacteriophage therapy Antimicrob. Agents Chemother. 45 2001 649 659
82. A. Sulakvelidze, and J.G. Morris Jr. Bacteriophages as therapeutic agents Ann. Med. 33 2001 507 509
83. K. Sushida, and N. Hirano Isolation from media of two bacteriophages, protamylase-H37Rv (Ph) active against Mycobacterium tuberculosis Am. Rev. Resp. Dis. 106 1972 269 276
84. M.H. Tageldin, A.M. El Hassan, and I.E. Mustafa Spontaneous release of mycophages from lysogenic bovine strains Tuberculosis 62 1981 263 269
85. M.F. Thorel, M. Krichevsky, and V.V. Levy-Frebault Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., and Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int. J. Sys. Bact. 40 1990 254 260
86. T.L. Timme, and P.J. Brennan Induction of bacteriophage from members of the Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum serocomplex J. Gen. Micro. 130 1984 2059 2066
87. J.E. Uzonna, P. Chilton, R.H. Whitlock, P.L. Habecker, P. Scott, and R.W. Sweeney Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model Vaccine 21 2003 3101 3109
88. H. Vallee, and P. Rinjard Etudes sur l'enterite paratuberculeuse des bovides Rev. Gen. Med. Vet. 35 1926 1 9
89. G. van Schaik, C.H. Kalis, G. Benedictus, A.A. Dijkhuizen, and R.B. Huirne Cost-benefit analysis of vaccination against paratuberculosis in dairy cattle Vet. Rec. 139 1996 624 627
90. B. Wagland, D.L. Emery, and S.J. McClure Studies on the host-parasite relationship between Trichostrongylus colubriformis and susceptible and resistant sheep Int. J. Parasitol. 26 1996 1279 1286
91. J. Wang, and Z. Xing Tuberculosis vaccines: the past, present and future Exp. Rev. Vaccine 1 2002 341 354
92. B. Weber-Dabrowska, M. Mulczyk, and A. Gorski Bacteriophage therapy of bacterial infections: an update of our institute's experience Arch. Immunol. Ther. Exp. 48 2000 547 551
93. D.N. Wedlock, M.A. Skinner, N.A. Parlane, H.M. Vordermeier, R.G. Hewinson, G.W. de Lisle, B.M. Buddle, D. Keen, R.E. Tascon, J.C. Ferraz, D.B. Lowrie, and P.J. Cockle Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis Tuberculosis (Edinb) 83 2003 339 349
94. G.H. Wentink, J.H. Bongers, A.A. Zeeuwen, and F.H. Jaartsveld Incidence of paratuberculosis after vaccination against M. paratuberculosis in two infected dairy herds Zentr. Veter. Reihe B 41 1994 517 522
95. R. Whittington, D.J. Marshall, P.J. Nicholls, I.B. Marsh, and L.A. Reddacliff Survival and dormancy of Mycobacterium avium subsp. paratuberculosis in the environment Appl. Env. Micro. 70 2004 2989 3004
96. R. Whittington, L.A. Reddacliff, I. Marsh, S. McAllister, and V. Saunders Temporal patterns and quantification of excretion of Mycobacterium avium subsp. paratuberculosis in sheep with Johne's disease Aust. Vet. J. 78 2000 34 37
97. R. Whittington, C.A. Taragel, S. Ottaway, I. Marsh, J. Seaman, and V. Fridriksdottir Molecular epidemiological confirmation of occurence of sheep (S) atrains of Mycobacterium avium subsp. paratuberculosis in cases of paratuberculosis in cattle in Australia and sheep in Iceland Vet. Micro. 79 2000 311 322
98. J. Wilesmith Johne's disease: a retrospective study of vaccinated herds in Great Britain Br. Vet. J. 138 1982 321 330
99. M. Wilkinson Predation in the presence of decoys: an inhibitory factor on pathogen control by bacteriophages or bdellovirus in dense and diverse ecosystems J. Theoret. Biol. 208 2001 27 36
100. M. Zahinuddin, and R.P. Sinha Effect of antituberculous agents on Mycobacterium johnei in infected goats Ind. Vet. J. 61 1984 574 577
101. Z.S. Zemskova, and I.R. Dorozhkova Pathomorphological evaluation of therapeutic effect of mycobacteriophages in tuberculosis Probl. Tuberk. 11 1991 63 66